HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply

This article was originally published in The Tan Sheet

Executive Summary

FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney

You may also be interested in...

AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids

The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products

FDA Enforcement Follow-Through Could Thin Out Violators

FDA's emphasis on follow-through in its revamped enforcement strategy may help weed out bad actors from legitimate industry

FDA Learned Consumer Protection Lesson From 2004 Flu Scare

The roster of teams FDA assembled to respond to the 2009-N1H1 flu outbreak includes a consumer protection group to identify potentially dangerous products marketed as cures for the virus

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts